Vesalio and PrismaPlus Partnership Meeting in Frankfurt, Germany

Vesalio and PrismaPlus team members gathered in Frankfurt, Germany on January 15 to discuss marketing plans for the new year. NeVa clinical initiatives and new product introductions were reviewed to build on 2018 achievements in Germany. Vesalio’s innovative neurothrombectomy platform combined with the sales and marketing capabilities of PrismaPlus will lead to exciting advancements in stroke treatment in 2019…neva1stpass in Germany!



#DoTheDropZone #NeVa1stPass #LeaveNoClotBehind #Stroke #neuroendovascular #mechanicalthrombectomy #vesalio #ischemicstroke #thrombosis #bloodclot #thrombectomy #clot #ischemicstroketreatment #endovascularprocedures #endovascularinterventions #neurotechnology #stentretriever #acuteischemicstroke

Vesalio_CircleLogo_White.png
  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon

NeVa T, M1, M1-S and VS are CE-Marked

Caution - Investigational Device Limited by Federal Law

to Investigational Use.

150x132_graphic_logo_web.gif